Skip to main content
SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD logo

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD — Investor Relations & Filings

Ticker · 688389 ISIN · CNE100005WZ5 Shanghai Stock Exchange Manufacturing
Filings indexed 812 across all filing types
Latest filing 2025-06-24 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688389

About SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD

https://en.lifotronic.com/

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD. specializes in the research, development, and manufacturing of medical equipment for therapeutic and diagnostic applications. The company’s therapeutic portfolio includes negative pressure wound therapy (NPWT) systems, high-frequency chest wall oscillation devices for airway clearance, and various physical therapy and rehabilitation solutions. In the field of in-vitro diagnostics, it offers high-performance liquid chromatography (HPLC) hemoglobin analyzers for diabetes management and chemiluminescence immunoassay (CLIA) platforms. Lifotronic integrates advanced engineering with clinical requirements to provide solutions for wound care, respiratory health, and laboratory testing. The company serves a global market, focusing on technological innovation and the delivery of precise, reliable medical instruments designed to improve patient outcomes across diverse clinical settings.

Recent filings

Filing Released Lang Actions
北京市中伦(深圳)律师事务所关于深圳普门科技股份有限公司2021年、2022年、2023年、2024年股票期权激励计划相关事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the stock option incentive plans of Shenzhen Pumen Technology Co., Ltd. for the years 2021 to 2024. It discusses the legal compliance, approval, authorization, price adjustments, cancellations, and exercise of stock options under these plans. The document includes detailed legal analysis, references to company board and shareholder meetings, and compliance with relevant laws and regulations. It is not a financial report, earnings release, or management discussion, but a legal opinion related to stock option incentive plans. This type of document fits best under the category of Regulatory Filings (RNS) as it is a compliance/legal opinion document that does not fall under other specific categories such as Remuneration Information or Board/Management Information. The document length is substantial and contains detailed legal content, not merely an announcement or certification, so it is not RPA or a certification filing. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-06-24 Chinese
深圳普门科技股份有限公司监事会对2022年股票期权激励计划行权相关事项的核查意见
Regulatory Filings Classification · 90% confidence The document is a supervisory board's verification opinion on the exercise of stock options under the 2022 stock option incentive plan. It references compliance with laws and regulations and confirms the legitimacy and conditions of stock option exercises by 56 incentive recipients. The document is short (1042 characters) and focuses on a specific internal governance matter related to stock option exercises, not a full financial report or earnings release. It is not an announcement of voting results, nor a general regulatory filing. The content aligns with a report on a specific governance or management issue related to stock incentives, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like Remuneration Information or Director's Dealing. Therefore, the classification is RNS with high confidence.
2025-06-24 Chinese
深圳普门科技股份有限公司关于2022年股票期权激励计划首次授予股票期权第三个行权期自主行权实施公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the implementation of the third exercise period of a stock option incentive plan for the year 2022 by Shenzhen Pumen Technology Co., Ltd. It includes specifics about the stock options granted, exercise conditions, adjustments to exercise prices, cancellations of unexercised options, and legal opinions. The document is not a financial report, earnings release, or management discussion but rather a formal announcement about stock option exercises and related corporate actions. This fits the category of a Capital/Financing Update (CAP), as it deals with stock option exercises, issuance of shares upon exercise, and related capital structure changes. The document length and detail confirm it is not a brief announcement or a simple notice but a substantive update on financing-related corporate actions.
2025-06-24 Chinese
深圳普门科技股份有限公司关于2022年股票期权激励计划首次授予部分股票期权及2023年、2024年股票期权激励计划部分股票期权注销完成的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from Shenzhen Pumen Technology Co., Ltd. regarding the cancellation of certain stock options under the company's 2022, 2023, and 2024 stock option incentive plans. It details the reasons for the cancellation, such as unexercised options, employee departures, and unmet performance conditions. The document also states that the cancellation has been completed and will not affect the company's capital structure or financial condition. This type of announcement relates to changes in the company's capital structure specifically concerning stock options. It is not a full financial report, audit, or management discussion, nor is it a regulatory filing or report publication announcement. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes including stock option cancellations.
2025-06-16 Chinese
北京市中伦(深圳)律师事务所关于深圳普门科技股份有限公司2021年、2022年、2023年、2024年股票期权激励计划相关事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the stock option incentive plans of Shenzhen Pumen Technology Co., Ltd. for the years 2021 to 2024. It discusses the legal compliance, approval, authorization, price adjustments, cancellations, and exercise conditions of stock options. The document references specific board meetings, supervisory meetings, shareholder meetings, and audit reports related to these stock option plans. It is a detailed legal opinion on stock option incentive matters rather than a financial report, earnings release, or management discussion. It is not a proxy solicitation, voting results announcement, or remuneration report. The document is a standalone legal opinion related to corporate governance and stock option incentive plans, which fits best under the category of Regulatory Filings (RNS) because it is a legal compliance document and does not fit other more specific categories such as Board/Management Information or Remuneration Information. The document length is substantial and contains detailed legal analysis, not just an announcement or summary, so it is not a Report Publication Announcement (RPA). Therefore, the best classification is Regulatory Filings (RNS).
2025-05-28 Chinese
深圳普门科技股份有限公司关于注销2022年股票期权激励计划首次授予部分股票期权的公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement from Shenzhen Pumen Technology Co., Ltd. regarding the cancellation of certain stock options under the 2022 stock option incentive plan. It includes specifics about board and supervisory meetings, approval procedures, stock option grant dates, exercise periods, reasons for cancellation (such as unexercised options, employee departures, and unmet performance conditions), and legal opinions. The content focuses on changes to the company's stock option incentive plan and related corporate governance matters. It is not a financial report, earnings release, or investor presentation. It is also not a proxy solicitation or voting results announcement. The document is a formal announcement about management decisions related to stock option cancellations and adjustments, which fits best under the category of Board/Management Information (MANG), as it involves board resolutions and management decisions about stock option plans.
2025-05-28 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.